everolimus vipharm 10 mg tabletki
vipharm s.a. - everolimusum - tabletki - 10 mg
certican tabletki 0,5 mg tabletki
novartis poland sp. z o.o. - everolimusum - tabletki - 0,5 mg
certican tabletki 0,25 mg tabletki
novartis poland sp. z o.o. - everolimusum - tabletki - 0,25 mg
certican tabletki 0,75 mg tabletki
novartis poland sp. z o.o. - everolimusum - tabletki - 0,75 mg
kisplyx
eisai gmbh - mesilan lenvatinibu - rak, komórka nerek - Środki przeciwnowotworowe - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
aporami 1,25 mg tabletki
aurovitas pharma polska sp. z o.o. - ramiprilum - tabletki - 1,25 mg
aporami 2,5 mg tabletki
aurovitas pharma polska sp. z o.o. - ramiprilum - tabletki - 2,5 mg
aporami 10 mg tabletki
aurovitas pharma polska sp. z o.o. - ramiprilum - tabletki - 10 mg
aporami 5 mg tabletki
aurovitas pharma polska sp. z o.o. - ramiprilum - tabletki - 5 mg
locaring 150 mg kapsułki twarde
actavis group ptc ehf. - fluconazolum - kapsułki twarde - 150 mg